We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep in rats.
Six years on from the legalisation of medical cannabis in the UK, new figures reveal lack of NHS prescribing.
The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of the Citizens’ Assembly.
Findings have identified a significant decline in the percentage of US adolescents reporting current cannabis use.
Events will take place at several major cities around the UK to mark the sixth anniversary of the law change.
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the...
The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain.
The majority of doctors can now prescribe for reimbursement without prior approval of the health insurance companies.
It is the first comprehensive review of evidence on medical cannabis and epilepsy for clinicians, patients, and regulators.
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant...
